Selvita books PLN 9.38 million of net profit in Q4 2021

Selvita recorded PLN 9.38 million of consolidated net profit in Q4 2021 compared to PLN 5.42 million profit a year earlier, the company said in the report. Consolidated net profit without the impact of the incentive program amounted to PLN 20.85 million in Q4 2021 compared to PLN 5.42 million profit a year earlier.

The operating profit amounted to PLN 5.91 million versus PLN 3.77 million profit a year earlier. Without the impact of the incentive program, the EBIT profit amounted to PLN 17.38 million compared to PLN 3.77 million profit a year earlier. The EBITDA result reached PLN 15.63 million compared to PLN 7.82 million a year earlier.

Without the impact of the incentive program, EBITDA was PLN 27.1 million compared to PLN 7.82 million a year earlier.

“The past year was a breakthrough for us. Joining forces with Fidelta and further dynamic organic growth allowed us to increase revenues more than twice while maintaining high profitability. Considering the equally strong year 2020, we managed to implement the strategy planned for four years in just two years. Despite such a dynamic development and a significant increase in the scale of operations, we are invariably able to generate high margins, and we are entering the new year with contracts of over PLN 220 million, which will ensure further development in all segments “- commented President Bogusław Sieczkowski.

On a standalone basis, the net profit in 2021 amounted to PLN 12.65 million compared to PLN 10.85 million profit a year earlier.

Selvita shares (previously Selvita CRO S.A.) debuted in mid-October 2019 on the main market of the Warsaw Stock Exchange. Earlier, the registry court approved the division of Selvita. The court’s decision meant for Selvita S.A. formal finalization of the procedure related to the division of the company into two independent entities – Selvita S.A. (formerly Selvita CRO S.A.) and Ryvu Therapeutics S.A. (formerly Selvita S.A.).

Source

Our privacy policy
%d bloggers like this: